- Home
- BTOG vs EVGN Comparison
BTOG vs EVGN Comparison
Compare BTOG & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTOG
- EVGN
- Stock Information
- Founded
- BTOG 2018
- EVGN 1999
- Country
- BTOG Singapore
- EVGN Israel
- Employees
- BTOG N/A
- EVGN N/A
- Industry
- BTOG Finance: Consumer Services
- EVGN Agricultural Chemicals
- Sector
- BTOG Finance
- EVGN Industrials
- Exchange
- BTOG Nasdaq
- EVGN Nasdaq
- Market Cap
- BTOG 11.0M
- EVGN 9.7M
- IPO Year
- BTOG 2019
- EVGN N/A
- Fundamental
- Price
- BTOG $1.37
- EVGN $1.73
- Analyst Decision
- BTOG
- EVGN Strong Buy
- Analyst Count
- BTOG 0
- EVGN 1
- Target Price
- BTOG N/A
- EVGN $12.00
- AVG Volume (30 Days)
- BTOG 126.1K
- EVGN 793.3K
- Earning Date
- BTOG 01-01-0001
- EVGN 11-21-2024
- Dividend Yield
- BTOG N/A
- EVGN N/A
- EPS Growth
- BTOG N/A
- EVGN N/A
- EPS
- BTOG N/A
- EVGN N/A
- Revenue
- BTOG $7,088,763.00
- EVGN $9,449,000.00
- Revenue This Year
- BTOG N/A
- EVGN $173.12
- Revenue Next Year
- BTOG N/A
- EVGN $33.10
- P/E Ratio
- BTOG N/A
- EVGN N/A
- Revenue Growth
- BTOG 214.61
- EVGN 290.29
- 52 Week Low
- BTOG $1.28
- EVGN $1.70
- 52 Week High
- BTOG $9.71
- EVGN $10.40
- Technical
- Relative Strength Index (RSI)
- BTOG 32.23
- EVGN 31.26
- Support Level
- BTOG $1.38
- EVGN $1.70
- Resistance Level
- BTOG $2.29
- EVGN $2.10
- Average True Range (ATR)
- BTOG 0.28
- EVGN 0.21
- MACD
- BTOG -0.04
- EVGN -0.02
- Stochastic Oscillator
- BTOG 8.91
- EVGN 2.56
About BTOG Bit Origin Limited
Bit Origin Ltd is seeking opportunities in deploying new technologies, crypto asset mining and blockchain technologies in Singapore. The company has focused on building the Bitcoin mining ecosystem through incubations, strategic investments, and acquisitions.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.